<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Anal Cell Pathol (Amst)</journal-id><journal-id journal-id-type="iso-abbrev">Anal Cell Pathol (Amst)</journal-id><journal-id journal-id-type="publisher-id">ACP</journal-id><journal-title-group><journal-title>Analytical Cellular Pathology (Amsterdam)</journal-title></journal-title-group><issn pub-type="ppub">2210-7177</issn><issn pub-type="epub">2210-7185</issn><publisher><publisher-name>Hindawi</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7685809</article-id><article-id pub-id-type="doi">10.1155/2020/4282036</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Effects of <italic>Inonotus obliquus</italic> Polysaccharides on Proliferation, Invasion, Migration, and Apoptosis of Osteosarcoma Cells</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Su</surname><given-names>Baohui</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Yan</surname><given-names>Xuezhi</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Yuezhong</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Junshan</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-3766-9149</contrib-id><name><surname>Xia</surname><given-names>Xiaoyan</given-names></name><email>ziyi1314179@126.com</email><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="I1">
<sup>1</sup>Department of Spinal Surgery, Weifang People's Hospital, Weifang, Shandong 261041, China</aff><aff id="I2">
<sup>2</sup>Department of Surgery, Anqiu Municipal Hospital, Weifang, Shandong 262100, China</aff><author-notes><fn fn-type="other"><p>Academic Editor: Mahmoud Alhosin</p></fn></author-notes><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>17</day><month>11</month><year>2020</year></pub-date><volume>2020</volume><elocation-id>4282036</elocation-id><history><date date-type="received"><day>27</day><month>3</month><year>2020</year></date><date date-type="rev-recd"><day>28</day><month>10</month><year>2020</year></date><date date-type="accepted"><day>30</day><month>10</month><year>2020</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2020 Baohui Su et al.</copyright-statement><copyright-year>2020</copyright-year><license xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec><title>Objectives</title><p> To observe the effect of <italic>Inonotus obliquus</italic> polysaccharide (IOP) on the proliferation, invasion, migration, and apoptosis of osteosarcoma cells and to elucidate its underlying molecular mechanism. </p></sec><sec><title>Methods</title><p> IOP was extracted from <italic>Inonotus obliquus</italic>, human osteosarcoma MG-63 cells and U2OS cells were cultured in vitro, and the effects of IOP on the proliferation, migration, invasion, and apoptosis of MG-63 cells and U2OS cells were determined by CCK-8 assays, cell scratch assays, transwell assays, and flow cytometry, respectively. Western blot was used to detect the expression of related proteins in the Akt/mTOR and NF-<italic>&#x003ba;</italic>B signaling pathways. </p></sec><sec><title>Results</title><p> Compared with the control group, MG-63 cells and U2OS cells treated with IOP of 80&#x02009;<italic>&#x003bc;</italic>g/ml, 160&#x02009;<italic>&#x003bc;</italic>g/ml, and 320&#x02009;<italic>&#x003bc;</italic>&#x02009;g/ml in the experimental group had significantly lower proliferation activity, decreased migration and invasion ability, and increased apoptosis rate (<italic>P</italic> &#x0003c; 0.05). Furthermore, IOP could significantly inhibit the activation of the Akt/mTOR and NF-<italic>&#x003ba;</italic>B signaling pathway (<italic>P</italic> &#x0003c; 0.05). </p></sec><sec><title>Conclusion</title><p> IOP can regulate the proliferation, migration, invasion, and apoptosis of osteosarcoma cells by inhibiting the activation of the Akt/mTOR signaling pathway. It has antitumor activity on osteosarcoma and has the potential of clinical application in osteosarcoma treatment.</p></sec></abstract><funding-group><award-group><funding-source>Weifang City Health and Family Planning Commission Scientific Research Project Plan</funding-source><award-id>wfwsjs-2018-107</award-id></award-group></funding-group></article-meta></front><body><sec id="sec1"><title>1. Introduction</title><p>Osteosarcoma (OS) is a common malignant bone tumor that occurs mainly in adolescents and young people [<xref rid="B1" ref-type="bibr">1</xref>]. Osteosarcoma is an extremely aggressive malignant tumor characterized by rapid growth and early metastasis [<xref rid="B2" ref-type="bibr">2</xref>]. It is suggested that clinical prognosis from conventional osteosarcoma treatments such as surgery, radiotherapy, and chemotherapy is still not satisfactory [<xref rid="B3" ref-type="bibr">3</xref>]. Although new drugs have been applied in osteosarcoma chemotherapy, however, it could also result in strong drug resistance and unnecessary side effects, which can further cause serious problems [<xref rid="B4" ref-type="bibr">4</xref>]. Therefore, looking for a new targeted therapeutic drug is of great significance for preventing the progression of osteosarcoma and improving the survival of patients.</p><p>With the discovery of paclitaxel, the development of new tumor drugs has refocused on natural products. Particularly, in recent years, the application of natural products of medicinal plants in modern medicine is one of the important aspects of tumor treatment [<xref rid="B5" ref-type="bibr">5</xref>]. Among these natural products, polysaccharides are a class of biological macromolecules with great structural diversity, have no toxic effects, and have therapeutic values, so they have attracted widespread attention in the medical community [<xref rid="B6" ref-type="bibr">6</xref>]. Natural polysaccharides have a variety of pharmacological activities such as antitumor, immune regulation, antioxidation, antibacterial, and antiulcer [<xref rid="B7" ref-type="bibr">7</xref>]. Among them, their antitumor effects have an important application value. For example, many antitumor polysaccharides have been found to be nontoxic to normal cells and can induce apoptosis to various cancer cells [<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B9" ref-type="bibr">9</xref>].</p><p>
<italic>Inonotus obliquus</italic> fungus is a precious edible and medicinal fungus and has a long history as a traditional medicinal plant in China and other countries. It is reported that <italic>Inonotus obliquus</italic> has many biological functions, including antioxidant, antimitotic, and anti-inflammatory activities [<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B11" ref-type="bibr">11</xref>]. In particular, <italic>Inonotus obliquus</italic> polysaccharide (IOP) extracted from <italic>Inonotus obliquus</italic> fungus can be used to treat and prevent various diseases such as cancer [<xref rid="B12" ref-type="bibr">12</xref>], diabetes [<xref rid="B13" ref-type="bibr">13</xref>], pancreatitis [<xref rid="B14" ref-type="bibr">14</xref>], high lipidemia [<xref rid="B10" ref-type="bibr">10</xref>], colitis [<xref rid="B15" ref-type="bibr">15</xref>], and Alzheimer's disease [<xref rid="B16" ref-type="bibr">16</xref>]. However, the effect of IOP on osteosarcoma and its possible mechanism are still poorly understood. This study is to investigate the effect of IOP on the proliferation, invasion, migration, and apoptosis of osteosarcoma cells and its associated molecular mechanism, so as to provide a basis for the application of IOP in the treatment of osteosarcoma.</p></sec><sec id="sec2"><title>2. Materials and Methods</title><sec id="sec2.1"><title>2.1. Materials and Reagents</title><p>The CCK8 kit was purchased from MedChemExpress in the United States, the transwell cell was purchased from Corning in the United States, and the Annexin V-FITC/PI apoptosis kit was purchased from Sigma-Aldrich in the United States. Phospho-Akt (Ser473) antibody, Phospho-Akt (Thr308) antibody, Akt (pan) antibody, mTOR antibody, and Phospho-mTOR (Ser2448) antibody were purchased from Cell Signaling Technology, USA.</p></sec><sec id="sec2.2"><title>2.2. IOP Extraction and Identification</title><p>IOP was extracted according to the method of Xu et al. [<xref rid="B17" ref-type="bibr">17</xref>]. First, use the savage method to dissolve and remove the protein of Inonotus obliquus, then dialysis with tap water for 24 hours, and then with distilled water for 12 hours. The crude polysaccharide was centrifuged, lyophilized, and further purified in an anion exchange DEAE cellulose column (50cm &#x000d7; 2.6cm). Elute with 0&#x02009;M, 0.25&#x02009;m, and 0.5&#x02009;m NaCl solution at a flow rate of 0.4&#x02009;ml/min. Elute with 0.15&#x02009;m NaCl solution in a Sephadex G-200 gel column (1.6cm &#x000d7; 40cm) at a flow rate of 0.18&#x02009;ml/min. Collect the IOP, make it into a lyophilized powder, and store in an airtight container at 4&#x000b0;C.</p></sec><sec id="sec2.3"><title>2.3. Cell Culture and Treatment</title><p>Human osteosarcoma MG-63 cells and U2OS cells were purchased from Shanghai Fuheng Biotechnology Co., Ltd. and cultured in DMEM high-sugar medium containing 10% fetal bovine serum under 37&#x000b0;C with 5% CO<sub>2</sub>. 10&#x02009;<italic>&#x003bc;</italic>g/mL, 20&#x02009;<italic>&#x003bc;</italic>g/mL, 40&#x02009;<italic>&#x003bc;</italic>g/mL, 80&#x02009;<italic>&#x003bc;</italic>g/mL, 160&#x02009;<italic>&#x003bc;</italic>g/mL, and 320&#x02009;<italic>&#x003bc;</italic>g/mL of IOP were added to the medium for the treatments, and a group of cells without IOP was used as a negative control (NC).</p></sec><sec id="sec2.4"><title>2.4. Cell Proliferation Detected with CCK-8</title><p>MG-63 cells and U2OS cells were seeded in 96-well plates and treated with different concentrations of IOP. After the cells were incubated in the incubator for 24, 48, and 72&#x02009;h, 10&#x02009;<italic>&#x003bc;</italic>l of CCK8 solution was added to each well and incubated for a while. The absorbance at 450&#x02009;nm was measured with a spectrophotometer afterward.</p></sec><sec id="sec2.5"><title>2.5. Cell Migration Measured with Cell Scratch Test</title><p>Cell migration experiments were carried out using scratch experiments. Specifically, MG-63 cells and U2OS cells were seeded on 6-well plates, cultured overnight, and then treated with different concentrations of IOP for 24&#x02009;h. After that, scratch the cell layer with a sterile plastic pipette tip to form a scratch. The detached cells were rinsed off with PBS. After that, the DMEM medium containing 1% fetal bovine serum was added, the cells were cultured for 24&#x02009;h, photos were taken, and the cell migration rate was calculated accordingly.</p></sec><sec id="sec2.6"><title>2.6. Cell Invasion Determined by Transwell Cell Assay</title><p>Cell invasion tests were carried out using a matrix gel-coated transwell cell. Specifically, 1.0 &#x000d7; 10<sup>5</sup> MG-63 cells or U2OS cells treated with different concentrations of IOP for 24&#x02009;h were inoculated into the upper chamber with 100&#x02009;ml of serum-free DMEM, and 500&#x02009;ml of medium containing 10% FBS was added to the lower chamber. After 24&#x02009;h of incubation, the cells on the surface of the upper membrane were wiped with a cotton swab, and the cells passing through the membrane were fixed with methanol, stained with crystal violet, and counted afterward.</p></sec><sec id="sec2.7"><title>2.7. Cell Apoptosis Measured with Annexin V-FITC/PI Apoptosis Detection Kit</title><p>MG-63 cells and U2OS cells were seeded in 6-well plates at 4 &#x000d7; 10<sup>5</sup> cells per well and cultured overnight. The cells were treated with different concentrations of IOP for 24&#x02009;h. Cells were then collected, washed with PBS, and double-stained using Annexin V-FITC/PI apoptosis detection kit. Finally, flow cytometry was used to analyze the cell apoptotic rate.</p></sec><sec id="sec2.8"><title>2.8. Western Blot</title><p>After the cells were treated with different concentrations of IOP for 24&#x02009;h, the cells were washed twice with cold PBS. Total protein was then extracted using a RIPA lysis buffer supplemented with a protease inhibitor, and total protein was then quantified using a BCA protein concentration determination kit. An equal amount of protein (20&#x02009;<italic>&#x003bc;</italic>g/well) from each treatment was taken and subjected to SDS-PAGE electrophoresis, and the protein was then electrotransferred to a PVDF membrane. The membrane was then blocked with 5% skim milk at room temperature for 1&#x02009;h and then incubated with the primary antibody overnight at 4&#x000b0;C. The membrane was then washed and was incubated with the secondary antibody for 1&#x02009;h at room temperature. Protein bands were then detected using the ECL luminescence kit.</p></sec><sec id="sec2.9"><title>2.9. Statistical Analysis</title><p>All the data in this study were analyzed using SPSS software. Results are expressed as mean &#x000b1; standarddeviation. The <italic>t</italic>-test and one-way analysis of variance was used to compare the differences between groups. The difference was statistically significant at <italic>P</italic> &#x0003c; 0.05.</p></sec></sec><sec id="sec3"><title>3. Results</title><sec id="sec3.1"><title>3.1. IOP Identification by High-Performance Liquid Chromatography</title><p>IOP was analyzed with high-performance liquid chromatography as shown in <xref ref-type="fig" rid="fig1">Figure 1</xref>. We analyzed the monosaccharide composition of IOP. The monosaccharide composition of IOP is Man, Rha, Glu, Gal, Xyl, and Ara, and the molar ratio is 2.2&#x02009;:&#x02009;1.1&#x02009;:&#x02009;11.8&#x02009;:&#x02009;2.8&#x02009;:&#x02009;2.7&#x02009;:&#x02009;1.0.</p></sec><sec id="sec3.2"><title>3.2. IOP Inhibits MG-63 Cells and U2OS Cell Proliferation</title><p>As shown in <xref ref-type="fig" rid="fig2">Figure 2</xref>, CCK8 assay was used to measure the proliferation of MG-63 cells and U2OS cells, and after IOP was added to MG-63 cells and U2OS cells at different concentrations (10&#x02009;<italic>&#x003bc;</italic>g/mL, 20&#x02009;<italic>&#x003bc;</italic>g/mL, 40&#x02009;<italic>&#x003bc;</italic>g/mL, 80&#x02009;<italic>&#x003bc;</italic>g/mL, 160&#x02009;<italic>&#x003bc;</italic>g/mL, and 320&#x02009;<italic>&#x003bc;</italic>g/mL), compared with the control group, the cell proliferation activity was significantly reduced (<italic>P</italic> &#x0003c; 0.05) when the IOP was at the concentrations of 80&#x02009;<italic>&#x003bc;</italic>g/mL, 160&#x02009;<italic>&#x003bc;</italic>g/mL, and 320&#x02009;<italic>&#x003bc;</italic>g/mL after 48&#x02009;h and 72&#x02009;h of treatments. This result indicates that IOP can inhibit the proliferation of osteosarcoma cells.</p></sec><sec id="sec3.3"><title>3.3. IOP Inhibits MG-63 Cells and U2OS Cell Migration</title><p>As shown in <xref ref-type="fig" rid="fig3">Figure 3</xref>, after adding IOP to MG-63 cells and U2OS cells at different concentrations (80&#x02009;<italic>&#x003bc;</italic>g/mL, 160&#x02009;<italic>&#x003bc;</italic>g/mL, and 320&#x02009;<italic>&#x003bc;</italic>g/mL) compared with the control group, the migration activity of the cells was significantly reduced in the 80&#x02009;<italic>&#x003bc;</italic>g/mL, 160&#x02009;<italic>&#x003bc;</italic>g/mL, and 320&#x02009;<italic>&#x003bc;</italic>g/mL groups (<italic>P</italic> &#x0003c; 0.05). It is apparent that this inhibition on the MG-63 cells and U2OS cell migration by the treatment of IOP was in a dose-dependent manner. Overall, this result indicates that IOP can inhibit the migration of osteosarcoma cells.</p></sec><sec id="sec3.4"><title>3.4. IOP Inhibits MG-63 Cells and U2OS Cell Invasion</title><p>As shown in <xref ref-type="fig" rid="fig4">Figure 4</xref>, when IOP was added to MG-63 cells and U2OS cells at different concentrations (80&#x02009;<italic>&#x003bc;</italic>g/mL, 160&#x02009;<italic>&#x003bc;</italic>g/mL, and 320&#x02009;<italic>&#x003bc;</italic>g/mL) compared with the control group, the invasive ability of the cells was significantly reduced in the 80&#x02009;<italic>&#x003bc;</italic>g/mL, 160&#x02009;<italic>&#x003bc;</italic>g/mL, and 320&#x02009;<italic>&#x003bc;</italic>g/mL groups (<italic>P</italic> &#x0003c; 0.05). And this inhibition of cell invasion by the treatment of IOP was in a concentration-dependent manner. This result indicates that IOP can inhibit the invasion of osteosarcoma cells.</p></sec><sec id="sec3.5"><title>3.5. IOP Promotes Apoptosis of MG-63 Cells and U2OS Cells</title><p>As shown in <xref ref-type="fig" rid="fig5">Figure 5</xref>, after adding IOP to MG-63 cells and U2OS cells at different concentrations (80&#x02009;<italic>&#x003bc;</italic>g/mL, 160&#x02009;<italic>&#x003bc;</italic>g/mL, and 320&#x02009;<italic>&#x003bc;</italic>g/mL), compared with the control group, the apoptosis rate of the cells was significantly increased in the 80&#x02009;<italic>&#x003bc;</italic>g/mL, 160&#x02009;<italic>&#x003bc;</italic>g/mL, and 320&#x02009;<italic>&#x003bc;</italic>g/mL groups (<italic>P</italic> &#x0003c; 0.05), which was also in a dose-dependent manner. This result indicates that IOP can promote the apoptosis of osteosarcoma cells.</p></sec><sec id="sec3.6"><title>3.6. IOP Inhibits Akt/mTOR and NF-<italic>&#x003ba;</italic>B Signaling Pathway</title><p>As shown in <xref ref-type="fig" rid="fig6">Figure 6</xref>, after adding IOP to MG-63 cells and U2OS cells at different concentrations (80&#x02009;<italic>&#x003bc;</italic>g/mL, 160&#x02009;<italic>&#x003bc;</italic>g/mL, and 320&#x02009;<italic>&#x003bc;</italic>g/mL), compared with the control group, the phosphorylation levels of Akt and mTOR as well as NF-<italic>&#x003ba;</italic>B p65 were significantly reduced (<italic>P</italic> &#x0003c; 0.05) at all treatment groups. And with the increase of the IOP levels, the phosphorylation of Akt at Ser473 and Thr308 as well as the phosphorylation of mTOR at Ser2448 and NF-<italic>&#x003ba;</italic>B p65 decreased dramatically. This result indicates that IOP can inhibit the activation of the Akt/mTOR and NF-<italic>&#x003ba;</italic>B signaling pathways.</p></sec></sec><sec id="sec4"><title>4. Discussion</title><p>Osteosarcoma is one of the most common malignant bone tumors, which seriously endangers the health of adolescents. In recent years, with the development of chemotherapy drugs, the survival rate of osteosarcoma has improved; however, the overall effectiveness is still not satisfactory. Drug resistance and side effects are the leading causes of cancer treatment failure. Therefore, it is imperative to seek alternative methods, and it has become a hot spot for research. In China, IOP has been used as a folk medicine for treating cancer and other diseases for thousands of years [<xref rid="B18" ref-type="bibr">18</xref>]. However, little is known about the mechanisms behind it. Previous studies have shown that IOP can change energy metabolism through the LKB1/AMPK pathway and induce lung cancer cell apoptosis [<xref rid="B18" ref-type="bibr">18</xref>]; IOP can also reduce the expression of MMP-2 and MMP-9 by downregulating the NF-<italic>&#x003ba;</italic>B signaling pathway, thereby inhibiting the migration and invasion of B16-F10 cells [<xref rid="B19" ref-type="bibr">19</xref>]. This study intended to elucidate the role of IOP in osteosarcoma and its mechanism of inhibiting osteosarcoma cells and explore its potential value as a chemotherapeutic agent for osteosarcoma.</p><p>In this study, we first isolated and purified the polysaccharide IOP from Inonotus obliquus fungus and investigated its effect on the proliferation, migration, invasion, and apoptosis of osteosarcoma MG-63 cells and U2OS cells in vitro. CCK-8 experiments showed that IOP significantly inhibited the proliferation of MG-63 cells and U2OS cells. In particular, when the concentration of IOP was greater than 80&#x02009;/mL, the proliferation activity of MG-63 cells and U2OS cells was significantly downregulated compared with the control group. Similarly, cell scratch experiments have confirmed that IOP has a significant inhibitory effect on the migration capacity of MG-63 cells and U2OS cells, transwell experiments have shown that IOP has a significant inhibitory effect on the invasiveness of MG-63 cells and U2OS cells, and further apoptosis experiments have demonstrated that IOP can promote the apoptosis of MG-63 cells and U2OS cells. Therefore, taken all these together, our functional experiments showed that IOP has obvious antitumor activity on osteosarcoma cells and has the potential for clinical application in osteosarcoma treatment.</p><p>Further studies suggested that IOP can also inhibit the activation of the Akt/mTOR and NF-<italic>&#x003ba;</italic>B signaling pathway in osteosarcoma cells. Akt, also known as PKB (protein kinase B), is a serine/threonine-specific protein kinase that can be activated by PI3K at Thr308 and Ser473 sites. Activated Akt can activate the mTOR pathway in a variety of ways. And mTOR is an important serine-threonine protein kinase downstream of the PI3K/Akt signaling pathway which can regulate the malignant biological process of tumor cells by activating ribosomal kinase [<xref rid="B20" ref-type="bibr">20</xref>]. The Akt/mTOR signaling pathway is typically abnormally activated in a variety of malignant tumors and causes abnormal expression of downstream genes such as PFKFB2, p21, Vimentin, and Bcl-2.</p><p>Thereby, Akt/mTOR signaling pathway plays an important role in a variety of cellular biological processes of tumor cells, including autophagy, proliferation, migration, invasion, and apoptosis [<xref rid="B21" ref-type="bibr">21</xref>]. NF-<italic>&#x003ba;</italic>B has been shown to control the expression of tumor-related genes, such as Cyclin D1, c-Myc, HER2, interleukins, and XIAP, to regulate chronic inflammation, tumor cell survival, antiapoptosis, proliferation, invasion, and angiogenesis [<xref rid="B22" ref-type="bibr">22</xref>]. RelA/p65, which is a subunit of NF-<italic>&#x003ba;</italic>B, can increase transcription activity after phosphorylation, causing the activation of NF-<italic>&#x003ba;</italic>B, thereby promoting the transcription of related oncogenes [<xref rid="B23" ref-type="bibr">23</xref>]. In this study, it appears that IOP may regulate the proliferation, migration, invasion, and apoptosis of osteosarcoma cells by inhibiting the activation of the Akt/mTOR and NF-<italic>&#x003ba;</italic>B signaling pathway and further supplement the understanding of the antitumor mechanism of IOP.</p></sec><sec id="sec5"><title>5. Conclusion</title><p>The results of this study indicate that polysaccharide from <italic>Inonotus obliquus</italic> polysaccharide can regulate the proliferation, migration, invasion, and apoptosis of osteosarcoma cells by inhibiting the activation of the Akt/mTOR and NF-<italic>&#x003ba;</italic>B signaling pathway. This study also confirms that IOP has obvious antitumor activity against osteosarcoma and has the potential for clinical application in osteosarcoma treatment. At the same time, the molecular study provides a theoretical basis for the application of IOP in the treatment of osteosarcoma. However, this study lacks in vivo animal and clinical experiments, which are the shortcomings of this study and the direction for future development.</p></sec></body><back><ack><title>Acknowledgments</title><p>This work is supported by Weifang City Health and Family Planning Commission Scientific Research Project Plan (Grant no. wfwsjs-2018-107).</p></ack><sec sec-type="data-availability"><title>Data Availability</title><p>All the data is available with the handwritten notebook documented in our lab.</p></sec><sec sec-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare that there are no conflicts of interest regarding the publication of this paper.</p></sec><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yin</surname><given-names>F.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Jiang</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Reduction-responsive polypeptide nanomedicines significantly inhibit progression of orthotopic osteosarcoma</article-title><source><italic toggle="yes">Nanomedicine</italic></source><year>2020</year><volume>23</volume><fpage>p. 102085</fpage><pub-id pub-id-type="doi">10.1016/j.nano.2019.102085</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suehara</surname><given-names>Y.</given-names></name><name><surname>Alex</surname><given-names>D.</given-names></name><name><surname>Bowman</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Clinical genomic sequencing of pediatric and adult osteosarcoma reveals distinct molecular subsets with potentially targetable alterations</article-title><source><italic toggle="yes">Clinical Cancer Research</italic></source><year>2019</year><volume>25</volume><issue>21</issue><fpage>6346</fpage><lpage>6356</lpage><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-18-4032</pub-id><pub-id pub-id-type="pmid">31175097</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Cao</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>N.</given-names></name><etal/></person-group><article-title>Advances in differentiation therapy for osteosarcoma</article-title><source><italic toggle="yes">Drug Discovery Today</italic></source><year>2020</year><volume>25</volume><issue>3</issue><fpage>497</fpage><lpage>504</lpage><pub-id pub-id-type="doi">10.1016/j.drudis.2019.08.010</pub-id><pub-id pub-id-type="other">2-s2.0-85072226440</pub-id><pub-id pub-id-type="pmid">31499188</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marec-Berard</surname><given-names>P.</given-names></name><name><surname>Dalban</surname><given-names>C.</given-names></name><name><surname>Gaspar</surname><given-names>N.</given-names></name><etal/></person-group><article-title>A multicentric randomized phase II clinical trial evaluating high-dose thiotepa as adjuvant treatment to standard chemotherapy in patients with resectable relapsed osteosarcoma</article-title><source><italic toggle="yes">European Journal of Cancer</italic></source><year>2020</year><volume>125</volume><fpage>58</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1016/j.ejca.2019.11.007</pub-id><?supplied-pmid 31838406?><pub-id pub-id-type="pmid">31838406</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>X. M.</given-names></name><name><surname>Yang</surname><given-names>Z. J.</given-names></name><name><surname>Xie</surname><given-names>Q.</given-names></name><name><surname>Zhang</surname><given-names>Z. K.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Ma</surname><given-names>J. Y.</given-names></name></person-group><article-title>Natural products for treating colorectal cancer: a mechanistic review</article-title><source><italic toggle="yes">Biomedicine &#x00026; Pharmacotherapy</italic></source><year>2019</year><volume>117</volume><fpage>p. 109142</fpage><pub-id pub-id-type="doi">10.1016/j.biopha.2019.109142</pub-id><pub-id pub-id-type="other">2-s2.0-85067573786</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>He</surname><given-names>Y.</given-names></name><name><surname>Zeng</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Molecular basis for Poria cocos mushroom polysaccharide used as an antitumour drug in China</article-title><source><italic toggle="yes">Journal of Cellular and Molecular Medicine</italic></source><year>2019</year><volume>23</volume><issue>1</issue><fpage>4</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1111/jcmm.13564</pub-id><pub-id pub-id-type="other">2-s2.0-85056666085</pub-id><?supplied-pmid 30444050?><pub-id pub-id-type="pmid">30444050</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X. Y.</given-names></name><name><surname>Zhang</surname><given-names>D. D.</given-names></name><name><surname>Yin</surname><given-names>J. Y.</given-names></name><name><surname>Nie</surname><given-names>S. P.</given-names></name><name><surname>Xie</surname><given-names>M. Y.</given-names></name></person-group><article-title>Recent developments in Hericium erinaceus polysaccharides: extraction, purification, structural characteristics and biological activities</article-title><source><italic toggle="yes">Critical Reviews in Food Science and Nutrition</italic></source><year>2019</year><volume>59</volume><issue>Supplement 1</issue><fpage>S96</fpage><lpage>S115</lpage><pub-id pub-id-type="doi">10.1080/10408398.2018.1521370</pub-id><pub-id pub-id-type="other">2-s2.0-85067192553</pub-id><?supplied-pmid 30421988?><pub-id pub-id-type="pmid">30421988</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>K.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Extraction, characterization, antitumor and immunological activities of hemicellulose polysaccharide from astragalus radix herb residue</article-title><source><italic toggle="yes">Molecules</italic></source><year>2019</year><volume>24</volume><issue>20</issue><fpage>p. 3644</fpage><pub-id pub-id-type="doi">10.3390/molecules24203644</pub-id><pub-id pub-id-type="other">2-s2.0-85073095750</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>Y. Y.</given-names></name><name><surname>Ji</surname><given-names>H. Y.</given-names></name><name><surname>Dong</surname><given-names>X. D.</given-names></name><name><surname>Liu</surname><given-names>A. J.</given-names></name></person-group><article-title>An alcohol-soluble polysaccharide from Atractylodes macrocephala Koidz induces apoptosis of Eca-109 cells</article-title><source><italic toggle="yes">Carbohydrate Polymers</italic></source><year>2019</year><volume>226</volume><fpage>p. 115136</fpage><pub-id pub-id-type="doi">10.1016/j.carbpol.2019.115136</pub-id><pub-id pub-id-type="other">2-s2.0-85071739121</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Dong</surname><given-names>P.</given-names></name><name><surname>Fu</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name></person-group><article-title>Phytochemical characteristics and hypoglycaemic activity of fraction from mushroom Inonotus obliquus</article-title><source><italic toggle="yes">Journal of the Science of Food and Agriculture</italic></source><year>2010</year><volume>90</volume><issue>2</issue><fpage>276</fpage><lpage>280</lpage><pub-id pub-id-type="doi">10.1002/jsfa.3809</pub-id><pub-id pub-id-type="other">2-s2.0-70849128813</pub-id><?supplied-pmid 20355042?><pub-id pub-id-type="pmid">20355042</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>W.</given-names></name><name><surname>Miao</surname><given-names>K.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Chemical diversity of biologically active metabolites in the sclerotia of Inonotus obliquus and submerged culture strategies for up-regulating their production</article-title><source><italic toggle="yes">Applied Microbiology and Biotechnology</italic></source><year>2010</year><volume>87</volume><issue>4</issue><fpage>1237</fpage><lpage>1254</lpage><pub-id pub-id-type="doi">10.1007/s00253-010-2682-4</pub-id><pub-id pub-id-type="other">2-s2.0-77955552723</pub-id><pub-id pub-id-type="pmid">20532760</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>Y.</given-names></name><name><surname>Hui</surname><given-names>J.</given-names></name><name><surname>Kou</surname><given-names>W.</given-names></name><etal/></person-group><article-title>Identification of Inonotus obliquus and analysis of antioxidation and antitumor activities of polysaccharides</article-title><source><italic toggle="yes">Current Microbiology</italic></source><year>2008</year><volume>57</volume><issue>5</issue><fpage>454</fpage><lpage>462</lpage><pub-id pub-id-type="doi">10.1007/s00284-008-9233-6</pub-id><pub-id pub-id-type="other">2-s2.0-53849127828</pub-id><?supplied-pmid 18795365?><pub-id pub-id-type="pmid">18795365</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Hu</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Antidiabetic activities of polysaccharides separated from Inonotus obliquus via the modulation of oxidative stress in mice with streptozotocin-induced diabetes</article-title><source><italic toggle="yes">PLoS One</italic></source><year>2017</year><volume>12</volume><issue>6, article e0180476</issue><pub-id pub-id-type="doi">10.1371/journal.pone.0180476</pub-id><pub-id pub-id-type="other">2-s2.0-85021647276</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>Y.</given-names></name><name><surname>Teng</surname><given-names>C.</given-names></name><name><surname>Yu</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Inonotus obliquus polysaccharide regulates gut microbiota of chronic pancreatitis in mice</article-title><source><italic toggle="yes">AMB Express</italic></source><year>2017</year><volume>7</volume><issue>1</issue><fpage>p. 39</fpage><pub-id pub-id-type="doi">10.1186/s13568-017-0341-1</pub-id><pub-id pub-id-type="other">2-s2.0-85013080959</pub-id><?supplied-pmid 28197985?><pub-id pub-id-type="pmid">28197985</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y. F.</given-names></name><name><surname>Zheng</surname><given-names>J. J.</given-names></name><name><surname>Qu</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Inonotus obliquus polysaccharide ameliorates dextran sulphate sodium induced colitis involving modulation of Th1/Th2 and Th17/Treg balance</article-title><source><italic toggle="yes">Artificial Cells, Nanomedicine, and Biotechnology</italic></source><year>2019</year><volume>47</volume><issue>1</issue><fpage>757</fpage><lpage>766</lpage><pub-id pub-id-type="doi">10.1080/21691401.2019.1577877</pub-id><pub-id pub-id-type="other">2-s2.0-85062830538</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>Y.</given-names></name><name><surname>Nan</surname><given-names>S.</given-names></name><name><surname>Fan</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>Q.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name></person-group><article-title>Inonotus obliquus polysaccharides protect against Alzheimer's disease by regulating Nrf2 signaling and exerting antioxidative and antiapoptotic effects</article-title><source><italic toggle="yes">International Journal of Biological Macromolecules</italic></source><year>2019</year><volume>131</volume><fpage>769</fpage><lpage>778</lpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2019.03.033</pub-id><pub-id pub-id-type="other">2-s2.0-85063218084</pub-id><?supplied-pmid 30878614?><pub-id pub-id-type="pmid">30878614</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>L.</given-names></name><name><surname>Sang</surname><given-names>R.</given-names></name><name><surname>Yu</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Ge</surname><given-names>B.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name></person-group><article-title>The polysaccharide from Inonotus obliquus protects mice from Toxoplasma gondii-induced liver injury</article-title><source><italic toggle="yes">International Journal of Biological Macromolecules</italic></source><year>2019</year><volume>125</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2018.11.114</pub-id><pub-id pub-id-type="other">2-s2.0-85057764666</pub-id><pub-id pub-id-type="pmid">30445083</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>S.</given-names></name><name><surname>Shi</surname><given-names>F.</given-names></name><name><surname>Lin</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Inonotus obliquus polysaccharides induces apoptosis of lung cancer cells and alters energy metabolism via the LKB1/AMPK axis</article-title><source><italic toggle="yes">International Journal of Biological Macromolecules</italic></source><year>2020</year><volume>151</volume><fpage>1277</fpage><lpage>1286</lpage><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2019.10.174</pub-id><?supplied-pmid 31751687?><pub-id pub-id-type="pmid">31751687</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>K. R.</given-names></name><name><surname>Lee</surname><given-names>J. S.</given-names></name><name><surname>Kim</surname><given-names>Y. R.</given-names></name><name><surname>Song</surname><given-names>I. G.</given-names></name><name><surname>Hong</surname><given-names>E. K.</given-names></name></person-group><article-title>Polysaccharide from Inonotus obliquus inhibits migration and invasion in B16-F10 cells by suppressing MMP-2 and MMP-9 via downregulation of NF-<italic>&#x003ba;</italic>B signaling pathway</article-title><source><italic toggle="yes">Oncology Reports</italic></source><year>2014</year><volume>31</volume><issue>5</issue><fpage>2447</fpage><lpage>2453</lpage><pub-id pub-id-type="doi">10.3892/or.2014.3103</pub-id><pub-id pub-id-type="other">2-s2.0-84898670976</pub-id><?supplied-pmid 24677090?><pub-id pub-id-type="pmid">24677090</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Z.</given-names></name><name><surname>Han</surname><given-names>X.</given-names></name><name><surname>Ou</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Targeting PI3K/AKT/mTOR-mediated autophagy for tumor therapy</article-title><source><italic toggle="yes">Applied Microbiology and Biotechnology</italic></source><year>2020</year><volume>104</volume><issue>2</issue><fpage>575</fpage><lpage>587</lpage><pub-id pub-id-type="doi">10.1007/s00253-019-10257-8</pub-id><?supplied-pmid 31832711?><pub-id pub-id-type="pmid">31832711</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tewari</surname><given-names>D.</given-names></name><name><surname>Patni</surname><given-names>P.</given-names></name><name><surname>Bishayee</surname><given-names>A.</given-names></name><name><surname>Sah</surname><given-names>A. N.</given-names></name><name><surname>Bishayee</surname><given-names>A.</given-names></name></person-group><article-title>Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: a novel therapeutic strategy</article-title><source><italic toggle="yes">Seminars in Cancer Biology</italic></source><year>2019</year><pub-id pub-id-type="doi">10.1016/j.semcancer.2019.12.008</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmad</surname><given-names>A.</given-names></name><name><surname>Ahsan</surname><given-names>H.</given-names></name></person-group><article-title>Ras-mediated activation of NF-<italic>&#x003ba;</italic>B and DNA damage response in carcinogenesis</article-title><source><italic toggle="yes">Cancer Investigation</italic></source><year>2020</year><volume>38</volume><issue>4</issue><fpage>185</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1080/07357907.2020.1721523</pub-id><?supplied-pmid 31971023?><pub-id pub-id-type="pmid">31971023</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kabacaoglu</surname><given-names>D.</given-names></name><name><surname>Ruess</surname><given-names>D. A.</given-names></name><name><surname>Ai</surname><given-names>J.</given-names></name><name><surname>Alg&#x000fc;l</surname><given-names>H.</given-names></name></person-group><article-title>NF-<italic>&#x003ba;</italic>B/Rel transcription factors in pancreatic cancer: focusing on RelA, c-Rel, and RelB</article-title><source><italic toggle="yes">Cancers (Basel)</italic></source><year>2019</year><volume>11</volume><issue>7</issue><fpage>p. 937</fpage><pub-id pub-id-type="doi">10.3390/cancers11070937</pub-id><pub-id pub-id-type="other">2-s2.0-85068709739</pub-id><?supplied-pmid 31277415?><pub-id pub-id-type="pmid">31277415</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="fig1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>HPLC chart of IOP.</p></caption><graphic xlink:href="ACP2020-4282036.001"/></fig><fig id="fig2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>The effect of IOP on the proliferation activity of MG-63 cells and U2OS cells evaluated with CCK8. <sup>&#x02217;</sup><italic>P</italic> &#x0003c; 0.05.</p></caption><graphic xlink:href="ACP2020-4282036.002"/></fig><fig id="fig3" orientation="portrait" position="float"><label>Figure 3</label><caption><p>The effect of IOP on the migration activity of MG-63 cells and U2OS cells evaluated with the cell scratch test. <sup>&#x02217;</sup><italic>P</italic> &#x0003c; 0.05.</p></caption><graphic xlink:href="ACP2020-4282036.003"/></fig><fig id="fig4" orientation="portrait" position="float"><label>Figure 4</label><caption><p>The effect of IOP on the invasion ability of MG-63 cells and U2OS cells was determined with the transwell experiment. <sup>&#x02217;</sup><italic>P</italic> &#x0003c; 0.05.</p></caption><graphic xlink:href="ACP2020-4282036.004"/></fig><fig id="fig5" orientation="portrait" position="float"><label>Figure 5</label><caption><p>The effect of IOP on the apoptosis of MG-63 cells and U2OS cells was measured with flow cytometry. <sup>&#x02217;</sup><italic>P</italic> &#x0003c; 0.05.</p></caption><graphic xlink:href="ACP2020-4282036.005"/></fig><fig id="fig6" orientation="portrait" position="float"><label>Figure 6</label><caption><p>Effect of IOP on Akt/mTOR and NF-<italic>&#x003ba;</italic>B signaling pathway-related protein expression detected with Western blot. <sup>&#x02217;</sup><italic>P</italic> &#x0003c; 0.05.</p></caption><graphic xlink:href="ACP2020-4282036.006"/></fig></floats-group></article>